Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments
A Randomised Controlled Trial of Single Dose Tinidazole+Fluconazole Versus Longer Courses of Metronidazole+Clotrimazole in the Management of West African Women With Vaginal Discharge
1 other identifier
interventional
1,524
3 countries
7
Brief Summary
This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole for 7 days, plus vaginal clotrimazole for 3 days) in the syndromic management of women presenting with vaginal discharge in primary health care centers of Ghana, Togo, Guinea and Mali. It was designed as an effectiveness trial, i.e. it was done under conditions typical of routine work in these health centers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jan 2004
Shorter than P25 for phase_3
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 7, 2006
CompletedFirst Posted
Study publicly available on registry
April 11, 2006
CompletedApril 11, 2006
September 1, 2005
April 7, 2006
April 7, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptomatic resolution of the vaginal discharge according to the patient
Secondary Outcomes (1)
Objective resolution of the vaginal discharge according to the study nurse or medical officer
Interventions
Eligibility Criteria
You may qualify if:
- women consulting for vaginal discharge
- local resident
- willingness and ability to consent
You may not qualify if:
- sex worker consulting for active screening
- main complaint of lower abdominal pain
- allergy to one of the study drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Adabraka Polyclinic
Accra, Ghana
Suntreso Polyclinc
Kumasi, Ghana
Centre de Santé Carrière
Conakry, Guinea
Centre de Santé Madina
Conakry, Guinea
Centre de Santé d'Adakpamé
Adakpamé, Togo
Clinique IST d'Agoe Nyivé
Lomé, Togo
Clinique IST d'Amoutivé
Lomé, Togo
Related Publications (1)
Pepin J, Sobela F, Khonde N, Agyarko-Poku T, Diakite S, Deslandes S, Labbe AC, Sylla M, Asamoah-Adu C, Frost E. The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bull World Health Organ. 2006 Sep;84(9):729-38. doi: 10.2471/blt.06.029819.
PMID: 17128343DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacques Pepin, MD
U of Sherbrooke
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 7, 2006
First Posted
April 11, 2006
Study Start
January 1, 2004
Study Completion
May 1, 2005
Last Updated
April 11, 2006
Record last verified: 2005-09